MeSH term
Frequency | Condition_Probility | Cell Line, Tumor | 6 | 0.0 |
Female | 11 | 0.0 |
Humans | 86 | 0.0 |
Phosphoric Monoester Hydrolases/*genetics | 3 | 1.0 |
Research Support, Non-U.S. Gov't | 57 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Transfection | 13 | 0.0 |
Tumor Suppressor Proteins/*genetics | 2 | 1.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors/metabolism | 6 | 6.0 |
Apoptosis/drug effects/physiology | 2 | 2.0 |
Cells, Cultured | 19 | 0.0 |
Enzyme Inhibitors/pharmacology | 14 | 0.0 |
Phosphorylation/drug effects | 7 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 4 | 0.0 |
Proto-Oncogene Proteins/metabolism | 9 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 39 | 0.0 |
1-Phosphatidylinositol 3-Kinase/*antagonists & inhibitors/metabolism | 2 | 20.0 |
Androstadienes/pharmacology | 9 | 3.0 |
Dose-Response Relationship, Drug | 7 | 0.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 8 | 2.0 |
Adult | 5 | 0.0 |
Enzyme Activation | 7 | 0.0 |
Insulin/*pharmacology | 2 | 0.0 |
Middle Aged | 3 | 0.0 |
Phosphoproteins/*metabolism | 2 | 0.0 |
Phosphorylation | 19 | 0.0 |
Protein Kinase C/*metabolism | 2 | 0.0 |
Animals | 50 | 0.0 |
Apoptosis/*drug effects | 3 | 0.0 |
Cell Line | 15 | 0.0 |
*Protein-Serine-Threonine Kinases | 10 | 1.0 |
Proto-Oncogene Proteins/*metabolism | 4 | 0.0 |
1-Phosphatidylinositol 3-Kinase/*physiology | 7 | 13.0 |
Mitogen-Activated Protein Kinases/physiology | 3 | 2.0 |
Signal Transduction | 20 | 0.0 |
Cell Survival | 2 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 3 | 0.0 |
Tumor Necrosis Factor-alpha/*pharmacology | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 11 | 2.0 |
Disease Models, Animal | 2 | 0.0 |
Mice | 19 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 7 | 0.0 |
Enzyme Activation/drug effects | 3 | 0.0 |
*Proto-Oncogene Proteins | 4 | 0.0 |
Cell Proliferation | 2 | 1.0 |
Chromones/pharmacology | 6 | 2.0 |
Morpholines/pharmacology | 6 | 2.0 |
Sirolimus/pharmacology | 2 | 2.0 |
Tumor Cells, Cultured | 14 | 0.0 |
Amino Acid Sequence | 9 | 0.0 |
Base Sequence | 6 | 0.0 |
Exons | 2 | 0.0 |
Male | 9 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
Prostate/*metabolism | 2 | 2.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Rats | 10 | 0.0 |
English Abstract | 5 | 0.0 |
*Apoptosis | 2 | 0.0 |
Isoenzymes/metabolism | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Signal Transduction/drug effects/physiology | 3 | 1.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 6 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Protein Kinases/metabolism | 3 | 0.0 |
Signal Transduction/*physiology | 6 | 0.0 |
Trans-Activators/metabolism | 3 | 0.0 |
MAP Kinase Signaling System/drug effects | 2 | 2.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 3 | 1.0 |
Cloning, Molecular | 6 | 0.0 |
DNA, Complementary/analysis | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Blotting, Western | 7 | 0.0 |
Cell Separation | 3 | 0.0 |
Endothelium, Vascular/enzymology | 2 | 4.0 |
Flow Cytometry | 4 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 4 | 0.0 |
Thromboplastin/*metabolism | 2 | 1.0 |
Vascular Endothelial Growth Factor A | 2 | 0.0 |
Vascular Endothelial Growth Factors | 2 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 3 | 0.0 |
Phosphoproteins/genetics | 2 | 1.0 |
Cytoskeletal Proteins/metabolism | 2 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
NF-kappa B/metabolism | 4 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Caspases/metabolism | 2 | 0.0 |
Insulin-Like Growth Factor I/*pharmacology | 2 | 1.0 |
Protein-Serine-Threonine Kinases/pharmacology | 2 | 18.0 |
Proto-Oncogene Proteins/pharmacology | 2 | 9.0 |
Cell Division/drug effects/physiology | 2 | 0.0 |
Flavonoids/pharmacology | 3 | 0.0 |
Kinetics | 4 | 0.0 |
Signal Transduction/drug effects/*physiology | 2 | 0.0 |
Signal Transduction/*drug effects | 2 | 0.0 |
src-Family Kinases/metabolism | 2 | 1.0 |
In Vitro | 3 | 0.0 |
Membrane Potentials | 2 | 0.0 |
*Potassium Channel Blockers | 2 | 13.0 |
*Potassium Channels, Voltage-Gated | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase/physiology | 2 | 1.0 |
Patch-Clamp Techniques | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Time Factors | 4 | 0.0 |
DNA, Neoplasm/biosynthesis | 2 | 1.0 |
Mitogen-Activated Protein Kinases/antagonists & inhibitors/metabolism | 2 | 2.0 |
Hela Cells | 8 | 0.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors/*metabolism | 3 | 4.0 |
Cattle | 2 | 0.0 |
Precipitin Tests | 4 | 0.0 |
Blood Platelets/*metabolism | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Culture Media, Serum-Free | 2 | 0.0 |
3T3 Cells | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Ligands | 3 | 0.0 |
Protein Kinase C/antagonists & inhibitors/metabolism | 2 | 2.0 |
Binding Sites | 2 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Mutation | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Rats, Sprague-Dawley | 4 | 0.0 |
Tyrosine/metabolism | 3 | 0.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 3 | 0.0 |
Comparative Study | 6 | 0.0 |
Immune Sera/immunology | 2 | 1.0 |
Rabbits | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase | 3 | 2.0 |
Protein-Tyrosine Kinase/metabolism | 2 | 0.0 |
Caco-2 Cells | 2 | 0.0 |
Drug Interactions | 2 | 0.0 |
Drug Synergism | 2 | 0.0 |
Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors | 2 | 4.0 |
Adolescent | 3 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Respirovirus/*metabolism | 2 | 66.0 |
COS Cells | 2 | 0.0 |
*Cell Fusion | 3 | 8.0 |
Cercopithecus aethiops | 2 | 0.0 |
Parainfluenza Virus 3, Human/*physiology | 2 | 50.0 |
DNA Primers | 2 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Cell Differentiation/drug effects/*physiology | 2 | 3.0 |
Alleles | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Fetus | 2 | 0.0 |
Hamsters | 4 | 0.0 |
Parainfluenza Virus 3, Human/*immunology | 2 | 50.0 |
1-Phosphatidylinositol 3-Kinase/*antagonists & inhibitors | 3 | 15.0 |
Enzyme Inhibitors/*pharmacology | 3 | 0.0 |
MAP Kinase Signaling System/physiology | 2 | 2.0 |
*Sulfonamides | 2 | 3.0 |
Vero Cells | 2 | 0.0 |
Aged | 2 | 0.0 |
Necrosis | 2 | 0.0 |
Adaptation, Ocular | 2 | 50.0 |
Gene Expression Regulation | 2 | 0.0 |
